Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

ABIONYX Pharma - Filing #2816648

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Reserve of exchange differences on translation
87,000 EUR
39,000 EUR
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
8 821 EUR
255,000 EUR
Current assets
13 011 EUR
10 033 EUR
Non-current liabilities
4 408 EUR
61,000 EUR
Current liabilities
6 747 EUR
3 598 EUR
Revenue
675,000 EUR
Profit (loss)
5 822 EUR
5 822 EUR
1 886 EUR
1 886 EUR
Comprehensive income
5 759 EUR
1 891 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.